447 related articles for article (PubMed ID: 28871312)
1. ALK1 signaling in development and disease: new paradigms.
Roman BL; Hinck AP
Cell Mol Life Sci; 2017 Dec; 74(24):4539-4560. PubMed ID: 28871312
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
[TBL] [Abstract][Full Text] [Related]
3. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.
Fernández-L A; Sanz-Rodriguez F; Blanco FJ; Bernabéu C; Botella LM
Clin Med Res; 2006 Mar; 4(1):66-78. PubMed ID: 16595794
[TBL] [Abstract][Full Text] [Related]
4. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2.
Park SO; Lee YJ; Seki T; Hong KH; Fliess N; Jiang Z; Park A; Wu X; Kaartinen V; Roman BL; Oh SP
Blood; 2008 Jan; 111(2):633-42. PubMed ID: 17911384
[TBL] [Abstract][Full Text] [Related]
5. Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.
Garrido-Martin EM; Nguyen HL; Cunningham TA; Choe SW; Jiang Z; Arthur HM; Lee YJ; Oh SP
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2232-6. PubMed ID: 25082229
[TBL] [Abstract][Full Text] [Related]
6. BMP10 functions independently from BMP9 for the development of a proper arteriovenous network.
Choi H; Kim BG; Kim YH; Lee SJ; Lee YJ; Oh SP
Angiogenesis; 2023 Feb; 26(1):167-186. PubMed ID: 36348215
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cell biology of Endoglin in hereditary hemorrhagic telangiectasia.
Sugden WW; Siekmann AF
Curr Opin Hematol; 2018 May; 25(3):237-244. PubMed ID: 29438260
[TBL] [Abstract][Full Text] [Related]
8. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.
Ruiz-Llorente L; Gallardo-Vara E; Rossi E; Smadja DM; Botella LM; Bernabeu C
Expert Opin Ther Targets; 2017 Oct; 21(10):933-947. PubMed ID: 28796572
[TBL] [Abstract][Full Text] [Related]
9. Defective Flow-Migration Coupling Causes Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
Park H; Furtado J; Poulet M; Chung M; Yun S; Lee S; Sessa WC; Franco CA; Schwartz MA; Eichmann A
Circulation; 2021 Sep; 144(10):805-822. PubMed ID: 34182767
[TBL] [Abstract][Full Text] [Related]
10. Arteriovenous malformations in hereditary haemorrhagic telangiectasia: looking beyond ALK1-NOTCH interactions.
Peacock HM; Caolo V; Jones EA
Cardiovasc Res; 2016 Feb; 109(2):196-203. PubMed ID: 26645978
[TBL] [Abstract][Full Text] [Related]
11. ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.
Alsina-Sanchís E; García-Ibáñez Y; Figueiredo AM; Riera-Domingo C; Figueras A; Matias-Guiu X; Casanovas O; Botella LM; Pujana MA; Riera-Mestre A; Graupera M; Viñals F
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1216-1229. PubMed ID: 29449337
[TBL] [Abstract][Full Text] [Related]
12. Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions.
Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Pérez-Molino A; Hebbel RP; Nguyen J; Bernabéu C; Botella LM
Cardiovasc Res; 2005 Nov; 68(2):235-48. PubMed ID: 15993872
[TBL] [Abstract][Full Text] [Related]
13. Defective fluid shear stress mechanotransduction mediates hereditary hemorrhagic telangiectasia.
Baeyens N; Larrivée B; Ola R; Hayward-Piatkowskyi B; Dubrac A; Huang B; Ross TD; Coon BG; Min E; Tsarfati M; Tong H; Eichmann A; Schwartz MA
J Cell Biol; 2016 Sep; 214(7):807-16. PubMed ID: 27646277
[TBL] [Abstract][Full Text] [Related]
14. Nonfunctional TGF-β/ALK1/ENG signaling pathway supports neutrophil proangiogenic activity in hereditary hemorrhagic telangiectasia.
Duerig I; Pylaeva E; Ozel I; Wainwright S; Thiel I; Bordbari S; Domnich M; Siakaeva E; Lakomek A; Toppe F; Schleupner C; Geisthoff U; Lang S; Droege F; Jablonska J
J Leukoc Biol; 2023 Nov; 114(6):639-650. PubMed ID: 37555392
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology.
Ruiz S; Chandakkar P; Zhao H; Papoin J; Chatterjee PK; Christen E; Metz CN; Blanc L; Campagne F; Marambaud P
Hum Mol Genet; 2017 Dec; 26(24):4786-4798. PubMed ID: 28973643
[TBL] [Abstract][Full Text] [Related]
16. BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II.
Kim JH; Peacock MR; George SC; Hughes CC
Angiogenesis; 2012 Sep; 15(3):497-509. PubMed ID: 22622516
[TBL] [Abstract][Full Text] [Related]
17. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM
Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064
[TBL] [Abstract][Full Text] [Related]
18. Alk1 controls arterial endothelial cell migration in lumenized vessels.
Rochon ER; Menon PG; Roman BL
Development; 2016 Jul; 143(14):2593-602. PubMed ID: 27287800
[TBL] [Abstract][Full Text] [Related]
19. ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway.
Larrivée B; Prahst C; Gordon E; del Toro R; Mathivet T; Duarte A; Simons M; Eichmann A
Dev Cell; 2012 Mar; 22(3):489-500. PubMed ID: 22421041
[TBL] [Abstract][Full Text] [Related]
20. Hereditary haemorrhagic telangiectasia: a clinical and scientific review.
Govani FS; Shovlin CL
Eur J Hum Genet; 2009 Jul; 17(7):860-71. PubMed ID: 19337313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
